Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.

Gardette E, Moguelet P, Bouaziz JD, Lipsker D, Dereure O, Le Pelletier F, Lok C, Maisonobe T, Bessis D, Conard J, Francès C, Barete S.

Acta Derm Venereol. 2018 Oct 10;98(9):842-847. doi: 10.2340/00015555-2965.

2.

Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.

Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G.

Thromb Haemost. 2018 May;118(5):922-928. doi: 10.1055/s-0038-1641152. Epub 2018 Apr 3.

PMID:
29614525
3.

Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History.

Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G.

J Endocr Soc. 2017 Apr 20;1(6):762-771. doi: 10.1210/js.2017-00090. eCollection 2017 Jun 1.

4.

First venous thromboembolism and hormonal contraceptives in young French women.

Hugon-Rodin J, Horellou MH, Conard J, Flaujac C, Gompel A, Plu-Bureau G; and for the COntraception, REcurrent Venous Event (COREVE) investigators.

Medicine (Baltimore). 2017 Aug;96(34):e7734. doi: 10.1097/MD.0000000000007734.

5.

Retroperitoneal Fibrosis.

Conard J, Mancini M.

J Am Osteopath Assoc. 2017 May 1;117(5):340. doi: 10.7556/jaoa.2017.067. No abstract available.

PMID:
28459474
6.

Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals.

Lim MY, Deal AM, Kim S, Musty MD, Conard J, Simioni P, Dutrillaux F, Eid SS, Middeldorp S, Halbmayer WM, Boneu B, Moia M, Moll S.

Eur J Haematol. 2016 Oct;97(4):353-60. doi: 10.1111/ejh.12738. Epub 2016 Feb 18.

PMID:
26773706
7.

[Venous thromboembolic risk during repatriation for medical reasons].

Stansal A, Perrier E, Coste S, Bisconte S, Manen O, Lazareth I, Conard J, Priollet P.

J Mal Vasc. 2015 Dec;40(6):391-4. doi: 10.1016/j.jmv.2015.10.004. Epub 2015 Nov 6. Review. French.

PMID:
26548535
8.

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

Archer DF, Thomas MA, Conard J, Merkatz RB, Creasy GW, Roberts K, Plagianos M, Blithe D, Sitruk-Ware R.

Contraception. 2016 Jan;93(1):58-64. doi: 10.1016/j.contraception.2015.09.008. Epub 2015 Sep 25.

PMID:
26408374
9.

Tough Beginnings on Galapagos, Baby Blue Footed Booby.

Conard J.

Wilderness Environ Med. 2015 Sep;26(3):447. doi: 10.1016/j.wem.2015.02.002. Epub 2015 Mar 7. No abstract available.

PMID:
25758758
10.

Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French study.

Maitrot-Mantelet L, Horellou MH, Massiou H, Conard J, Gompel A, Plu-Bureau G.

Thromb Res. 2014 May;133(5):714-8. doi: 10.1016/j.thromres.2014.01.025. Epub 2014 Jan 29.

PMID:
24530211
11.

Prevention and treatment of venous thromboembolism--International Consensus Statement.

Nicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, Myers K, Samama M, Fletcher J, Kalodiki E, Bergqvist D, Bonnar J, Caprini JA, Carter C, Conard J, Eklof B, Elalamy I, Gerotziafas G, Geroulakos G, Giannoukas A, Greer I, Griffin M, Kakkos S, Lassen MR, Lowe GD, Markel A, Prandoni P, Raskob G, Spyropoulos AC, Turpie AG, Walenga JM, Warwick D.

Int Angiol. 2013 Apr;32(2):111-260.

PMID:
24402349
12.

[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays].

Samama MM, Conard J, Lillo-Le Louët A.

J Mal Vasc. 2013 Jul;38(4):259-70. doi: 10.1016/j.jmv.2013.05.005. Epub 2013 Jun 20. French.

PMID:
23790307
13.

[Aspirin and prevention of thromboembolism: the next chapter of a long story].

Ferrières C, Conard J, Blacher J.

J Mal Vasc. 2013 Feb;38(1):4-5. doi: 10.1016/j.jmv.2012.12.001. Epub 2013 Jan 11. French. No abstract available.

PMID:
23317999
14.

Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.

Gourdy P, Bachelot A, Catteau-Jonard S, Chabbert-Buffet N, Christin-Maître S, Conard J, Fredenrich A, Gompel A, Lamiche-Lorenzini F, Moreau C, Plu-Bureau G, Vambergue A, Vergès B, Kerlan V.

Ann Endocrinol (Paris). 2012 Nov;73(5):469-87. doi: 10.1016/j.ando.2012.09.001. Epub 2012 Oct 15.

PMID:
23078975
15.

[Pharmacologic heterogeneity of new anticoagulants].

Samamaa MM, Conard J, Flaujac C, Combe S, Horellou MH.

J Mal Vasc. 2011 Dec;36 Suppl 1:S10-5. doi: 10.1016/S0398-0499(11)70002-6. French.

PMID:
22177763
16.

Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia.

Pabinger I, Vossen CY, Lang J, Conard J, García-Dabrio MC, Miesbach W, Legnani C, Svensson P, Kaider A, Rosendaal FR.

J Thromb Haemost. 2012 Feb;10(2):217-22. doi: 10.1111/j.1538-7836.2011.04573.x.

17.

Risk assessment models for thromboprophylaxis of medical patients.

Samama MM, Combe S, Conard J, Horellou MH.

Thromb Res. 2012 Feb;129(2):127-32. doi: 10.1016/j.thromres.2011.09.025. Epub 2011 Nov 1. Review. No abstract available.

PMID:
22047755
18.

[Thrombosis and assisted reproductive techniques (ART)].

Conard J, Plu-Bureau G, Horellou MH, Samama MM, Gompel A.

J Mal Vasc. 2011 Jun;36(3):145-54. doi: 10.1016/j.jmv.2010.12.001. Epub 2011 Feb 17. Review. French.

PMID:
21333476
19.

Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.

Olié V, Plu-Bureau G, Conard J, Horellou MH, Canonico M, Scarabin PY.

Menopause. 2011 May;18(5):488-93. doi: 10.1097/gme.0b013e3181f9f7c3.

PMID:
21178641
20.

[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].

Samama M, Conard J, Horellou MH, Le Flem L, Guinet C, Depasse F.

Ann Pharm Fr. 2010 Nov;68(6):359-69. doi: 10.1016/j.pharma.2010.08.001. Epub 2010 Oct 29. Review. French.

PMID:
21073994
21.

[Perioperative use of antithrombotic agents: recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS)].

Samama MM, Horellou MH, Achkar A, Conard J; collaboration de F Mauriat.

J Mal Vasc. 2010 Jul;35(4):220-34. doi: 10.1016/j.jmv.2010.05.005. Epub 2010 Jul 23. French.

PMID:
20655153
22.

[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].

Conard J, Horellou MH, Samama MM; American College of Chest Physicians (ACCP).

J Mal Vasc. 2009 Nov;34(5):300-13. French.

PMID:
20050178
23.

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.

Hellgren M, Conard J, Norris L, Kluft C.

Maturitas. 2009 Mar 20;62(3):287-93. doi: 10.1016/j.maturitas.2009.01.004. Epub 2009 Mar 5.

PMID:
19268506
24.

Predictors of increased PaCO2 during immersed prone exercise at 4.7 ATA.

Cherry AD, Forkner IF, Frederick HJ, Natoli MJ, Schinazi EA, Longphre JP, Conard JL, White WD, Freiberger JJ, Stolp BW, Pollock NW, Doar PO, Boso AE, Alford EL, Walker AJ, Ma AC, Rhodes MA, Moon RE.

J Appl Physiol (1985). 2009 Jan;106(1):316-25. doi: 10.1152/japplphysiol.00885.2007. Epub 2008 Sep 11.

25.
26.

[Congenital protein S deficiencies; diagnostic difficulties].

Guermazi S, Conard J.

Pathol Biol (Paris). 2009 Sep;57(6):483-7. doi: 10.1016/j.patbio.2008.04.016. Epub 2008 Jun 25. French.

PMID:
18583066
27.

[Thrombophilias and peripheral arterial occlusive disease].

Le Hello C, Blacher J, Conard J, Piette JC, Constans J.

J Mal Vasc. 2008 Sep;33(3):126-36. doi: 10.1016/j.jmv.2008.04.008. Epub 2008 Jun 12. Review. French.

PMID:
18554834
28.

Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy.

Lebaudy C, Hulot JS, Amoura Z, Costedoat-Chalumeau N, Serreau R, Ankri A, Conard J, Cornet A, Dommergues M, Piette JC, Lechat P.

Clin Pharmacol Ther. 2008 Sep;84(3):370-7. doi: 10.1038/clpt.2008.73. Epub 2008 Apr 23.

PMID:
18431408
29.

[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].

Plu-Bureau G, Horellou MH, Gompel A, Conard J.

Gynecol Obstet Fertil. 2008 Apr;36(4):448-54. doi: 10.1016/j.gyobfe.2008.02.006. Epub 2008 Apr 18. Review. French.

PMID:
18424163
30.

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.

Tiede A, Tait RC, Shaffer DW, Baudo F, Boneu B, Dempfle CE, Horellou MH, Klamroth R, Lazarchick J, Mumford AD, Schulman S, Shiach C, Bonfiglio LJ, Frieling JT, Conard J, von Depka M.

Thromb Haemost. 2008 Mar;99(3):616-22. doi: 10.1160/TH07-08-0489.

PMID:
18327412
31.

Characterization of seven novel mutations causing factor XI deficiency.

Zucker M, Zivelin A, Landau M, Salomon O, Kenet G, Bauduer F, Samama M, Conard J, Denninger MH, Hani AS, Berruyer M, Feinstein D, Seligsohn U.

Haematologica. 2007 Oct;92(10):1375-80.

32.

[Pregnancy, contraception and HRT and venous thromboembolism].

Conard J, Gompel A.

Rev Prat. 2007 Apr 15;57(7):759-66. French.

PMID:
17626321
33.

Atypical mutations of the prothrombin gene at positions 20,209 and 20,218, and a novel mutation at position 20,219. Report on 10 patients.

Flaujac C, Conard J, Horellou MH, Le Flem L, Samama MM.

J Thromb Haemost. 2007 May;5(5):1064-8. No abstract available.

34.

Severe prekallikrein deficiencies due to homozygous C529Y mutations.

François D, Trigui N, Leterreux G, Flaujac C, Horellou MH, Mazaux L, Vignon D, Conard J, de Mazancourt P.

Blood Coagul Fibrinolysis. 2007 Apr;18(3):283-6.

PMID:
17413767
35.

Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.

Sitruk-Ware R, Plu-Bureau G, Menard J, Conard J, Kumar S, Thalabard JC, Tokay B, Bouchard P.

J Clin Endocrinol Metab. 2007 Jun;92(6):2074-9. Epub 2007 Mar 20.

PMID:
17374706
36.

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2007 Feb 20;115(7):840-5.

PMID:
17309934
37.

Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.

Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group.

J Thromb Haemost. 2006 Jun;4(6):1259-65.

38.

Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bbeta Y236C and Bbeta IVS7-1G-->C mutations.

Horellou MH, Chevreaud C, Mathieux V, Conard J, de Mazancourt P.

J Thromb Haemost. 2006 May;4(5):1134-6. No abstract available.

39.

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

Zivelin A, Mor-Cohen R, Kovalsky V, Kornbrot N, Conard J, Peyvandi F, Kyrle PA, Bertina R, Peyvandi F, Emmerich J, Seligsohn U.

Blood. 2006 Jun 15;107(12):4666-8. Epub 2006 Feb 21.

PMID:
16493002
40.

Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism.

Simon T, Beau Yon de Jonage-Canonico M, Oger E, Wahl D, Conard J, Meyer G, Emmerich J, Barrellier MT, Guiraud A, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group.

J Thromb Haemost. 2006 Jan;4(1):71-6.

41.

[Use of antithrombotic agents in pregnant women].

Conard J.

J Gynecol Obstet Biol Reprod (Paris). 2005 Dec;34(8):757-62. French.

42.

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.

Samama MM, Horellou MH, Elalamy I, Mathieux V, Ombandza-Moussa E, Conard J.

Semin Vasc Med. 2005 Nov;5(4):371-4. Review.

PMID:
16302158
43.

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.

Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2005 Nov 29;112(22):3495-500. Epub 2005 Nov 21.

PMID:
16301339
44.

Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.

Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R.

Fertil Steril. 2005 Nov;84(5):1345-51. Review.

PMID:
16275228
45.

[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians].

Achkar A, Horellou MH, Parent F, Elalamy I, Conard J, Samama MM, Simonneau G; Groupe des Maladies Vasculaires de la SPLF; Groupe Interdisciplinaire Trousseau sur les Antithrombotiques.

Rev Mal Respir. 2005 Nov;22(5 Pt 1):833-5. French. No abstract available.

PMID:
16272990
46.

[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].

Guermazi S, Conard J, Samama MM, Dellagi K.

Pathol Biol (Paris). 2006 Apr;54(3):159-65. Epub 2005 Sep 19. French.

PMID:
16176858
47.

Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.

Vossen CY, Walker ID, Svensson P, Souto JC, Scharrer I, Preston FE, Palareti G, Pabinger I, van der Meer FJ, Makris M, Fontcuberta J, Conard J, Rosendaal FR.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1992-7. Epub 2005 Jun 23.

PMID:
15976329
48.

[Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].

Samama MM, Rached RA, Conard J, Horellou MH, Elalamy I.

Bull Acad Natl Med. 2004;188(8):1377-93; discussion 1393-6. French.

PMID:
15918665
49.

Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

European Genetics Foundation; Cardiovascular Disease Educational and Research Trust; International Union of Angiology; Mediterranean League on Thromboembolism, Nicolaides AN, Breddin HK, Carpenter P, Coccheri S, Conard J, De Stefano V, Elkoofy N, Gerotziafas G, Guermazi S, Haas S, Hull R, kalodiki E, Kristof V, Michiels JJ, Myers K, Pineo G, Prandoni P, Romeo G, Samama MM, Simonian S, Xenophonthos S.

Int Angiol. 2005 Mar;24(1):1-26.

50.

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Vossen CY, Conard J, Fontcuberta J, Makris M, VAN DER Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR.

J Thromb Haemost. 2005 Mar;3(3):459-64.

Supplemental Content

Loading ...
Support Center